Skip to content
IHE-DCM

IHE-DCM

The IHE Diabetes Cohort Model (IHE-DCM) is a cohort-level, cost-effectiveness model developed for the evaluation of interventions in diabetes care. Designed to simulate disease progression over time, the model operates in annual cycles across a user-defined time horizon, uses Markov health states to capture key diabetes-related outcomes (microvascular, macrovascular, and mortality). IHE-DCM can be used to support early-stage decision making, market access, value story dissemination, post-marketing evidence needs and analyses of long-term cost and health implications of public health issues.

Key features of IHE-DCM

Model design

  • Separate models for type 1 diabetes and type 2 diabetes
  • Cohort approach with health states covering key micro- and macrovascular complications in diabetes
  • Flexible treatment sequence that permits modelling of a wide range of treatment profiles
  • Supports comparison of up to 12 treatments in a single simulation
  • Can be applied both deterministically and probabilistically
  • Continuously developed and updated

Practical use and accessibility

  • Entirely programmed in Microsoft® Excel – no need for external programs
  • User-friendly interface
  • Transparent and flexible design
  • Fast run times
  • Available through licensing or as part of individual projects

Validated and accepted  

  • Externally validated for different country settings
  • Accepted for use in reimbursement applications in multiple countries (e.g. in Sweden, Norway, Canada, and Australia)
  • Meets strict requirements of transparency of HTA authorities
  • Participated in the 2020, 2023 and 2025 Mount Hood Diabetes Challenge 

The IHE Diabetes Cohort Model (IHE-DCM)

For more information about IHE-DCM and publications, download our product information leaflet: IHE-DCM Product information leaflet (pdf)

For more information and queries, please contact Sofie Persson